HPV16 and Tumor Necrosis Factor Receptor Release
Author Information
Author(s): J Malejczyk, M Malejczyk, F Breitburd, S Majewski, A Schwarz, N Expert-Besanson, S Jablonska, G Orth, TA Luger
Hypothesis
Is the increased proliferation and tumorigenicity of SKv cells associated with their ability to release TNF inhibitory factors?
Conclusion
The study found that highly tumorigenic SKv-12 cells release significantly more soluble TNF receptor than weakly tumorigenic SKv-11 cells, which may contribute to their increased growth.
Supporting Evidence
- Highly tumorigenic SKv-12 cells released about 2-fold more soluble TNF receptor than weakly tumorigenic SKv-11 cells.
- The presence of soluble TNF receptor was confirmed by Western blot analysis.
- TNF inhibitory activity was specifically neutralized by antibodies targeting TNF receptor type I.
Takeaway
Some skin cells infected with a virus can release a substance that helps them grow faster by blocking signals that would normally stop their growth.
Methodology
The study involved analyzing conditioned media from keratinocyte cell lines and assessing their TNF inhibitory activity through various assays.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Want to read the original?
Access the complete publication on the publisher's website